Coexpression cluster:C206
From FANTOM5_SSTAR
Full id: C206_melanoma_somatostatinoma_nonsmall_small_neuroblastoma_smallcell_pituitary
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0008130 | neutrophil collagenase activity | 0.0276156719696426 |
GO:0035066 | positive regulation of histone acetylation | 0.0276156719696426 |
GO:0007586 | digestion | 0.0276156719696426 |
GO:0004232 | interstitial collagenase activity | 0.0276156719696426 |
GO:0031058 | positive regulation of histone modification | 0.0276156719696426 |
GO:0045722 | positive regulation of gluconeogenesis | 0.0276156719696426 |
GO:0035065 | regulation of histone acetylation | 0.0276156719696426 |
GO:0005515 | protein binding | 0.0276156719696426 |
GO:0046321 | positive regulation of fatty acid oxidation | 0.0281758957954588 |
GO:0031056 | regulation of histone modification | 0.0281758957954588 |
GO:0001678 | cell glucose homeostasis | 0.0281758957954588 |
GO:0006930 | substrate-bound cell migration, cell extension | 0.0281758957954588 |
GO:0006111 | regulation of gluconeogenesis | 0.0281758957954588 |
GO:0046320 | regulation of fatty acid oxidation | 0.0281758957954588 |
GO:0008133 | collagenase activity | 0.0281758957954588 |
GO:0050873 | brown fat cell differentiation | 0.0281758957954588 |
GO:0032502 | developmental process | 0.0281758957954588 |
GO:0045923 | positive regulation of fatty acid metabolic process | 0.0281758957954588 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 0.0281758957954588 |
GO:0048856 | anatomical structure development | 0.0281758957954588 |
GO:0016477 | cell migration | 0.0281758957954588 |
GO:0045913 | positive regulation of carbohydrate metabolic process | 0.0281758957954588 |
GO:0001659 | thermoregulation | 0.0281758957954588 |
GO:0030036 | actin cytoskeleton organization and biogenesis | 0.0281758957954588 |
GO:0006109 | regulation of carbohydrate metabolic process | 0.0281758957954588 |
GO:0019217 | regulation of fatty acid metabolic process | 0.0281758957954588 |
GO:0050930 | induction of positive chemotaxis | 0.0281758957954588 |
GO:0030029 | actin filament-based process | 0.0281758957954588 |
GO:0006929 | substrate-bound cell migration | 0.0281758957954588 |
GO:0032501 | multicellular organismal process | 0.0281758957954588 |
GO:0005102 | receptor binding | 0.0281758957954588 |
GO:0050926 | regulation of positive chemotaxis | 0.0281758957954588 |
GO:0045834 | positive regulation of lipid metabolic process | 0.0281758957954588 |
GO:0050927 | positive regulation of positive chemotaxis | 0.0281758957954588 |
GO:0050918 | positive chemotaxis | 0.0281758957954588 |
GO:0051054 | positive regulation of DNA metabolic process | 0.0281758957954588 |
GO:0050921 | positive regulation of chemotaxis | 0.0301518298716268 |
GO:0050920 | regulation of chemotaxis | 0.0320230610583892 |
GO:0042594 | response to starvation | 0.0329527024966334 |
GO:0016573 | histone acetylation | 0.0329527024966334 |
GO:0051130 | positive regulation of cellular component organization and biogenesis | 0.0337842185434333 |
GO:0050821 | protein stabilization | 0.0337842185434333 |
GO:0004697 | protein kinase C activity | 0.0337842185434333 |
GO:0001565 | phorbol ester receptor activity | 0.0337842185434333 |
GO:0042593 | glucose homeostasis | 0.0337842185434333 |
GO:0016455 | RNA polymerase II transcription mediator activity | 0.0337842185434333 |
GO:0045444 | fat cell differentiation | 0.0337842185434333 |
GO:0033500 | carbohydrate homeostasis | 0.0337842185434333 |
GO:0001541 | ovarian follicle development | 0.0348688036687015 |
GO:0006928 | cell motility | 0.0348688036687015 |
GO:0051674 | localization of cell | 0.0348688036687015 |
GO:0030574 | collagen catabolic process | 0.0348688036687015 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 0.0348688036687015 |
GO:0044254 | multicellular organismal protein catabolic process | 0.0348688036687015 |
GO:0044268 | multicellular organismal protein metabolic process | 0.0348688036687015 |
GO:0044256 | protein digestion | 0.0348688036687015 |
GO:0044266 | multicellular organismal macromolecule catabolic process | 0.0348688036687015 |
GO:0006473 | protein amino acid acetylation | 0.0348688036687015 |
GO:0044243 | multicellular organismal catabolic process | 0.0348688036687015 |
GO:0031647 | regulation of protein stability | 0.0348688036687015 |
GO:0032963 | collagen metabolic process | 0.0348688036687015 |
GO:0050681 | androgen receptor binding | 0.0356450507091056 |
GO:0044236 | multicellular organismal metabolic process | 0.0356450507091056 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 0.0356450507091056 |
GO:0030595 | leukocyte chemotaxis | 0.0356450507091056 |
GO:0003779 | actin binding | 0.0356450507091056 |
GO:0005100 | Rho GTPase activator activity | 0.0356450507091056 |
GO:0022601 | menstrual cycle phase | 0.0356450507091056 |
GO:0006094 | gluconeogenesis | 0.0356450507091056 |
GO:0022602 | menstrual cycle process | 0.0356450507091056 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 0.0356450507091056 |
GO:0008585 | female gonad development | 0.0369103935828845 |
GO:0019216 | regulation of lipid metabolic process | 0.0369103935828845 |
GO:0032989 | cellular structure morphogenesis | 0.0369103935828845 |
GO:0000902 | cell morphogenesis | 0.0369103935828845 |
GO:0006090 | pyruvate metabolic process | 0.0369103935828845 |
GO:0046660 | female sex differentiation | 0.0369103935828845 |
GO:0019395 | fatty acid oxidation | 0.0369103935828845 |
GO:0046545 | development of primary female sexual characteristics | 0.0369103935828845 |
GO:0006996 | organelle organization and biogenesis | 0.0369103935828845 |
GO:0035258 | steroid hormone receptor binding | 0.0374685021035196 |
GO:0050900 | leukocyte migration | 0.0377794999277673 |
GO:0043543 | protein amino acid acylation | 0.0377794999277673 |
GO:0000428 | DNA-directed RNA polymerase complex | 0.0378718921375282 |
GO:0042698 | menstrual cycle | 0.0378718921375282 |
GO:0005184 | neuropeptide hormone activity | 0.0378718921375282 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 0.0378718921375282 |
GO:0048731 | system development | 0.0378718921375282 |
GO:0030521 | androgen receptor signaling pathway | 0.0378718921375282 |
GO:0030880 | RNA polymerase complex | 0.0378718921375282 |
GO:0005615 | extracellular space | 0.0378718921375282 |
GO:0019319 | hexose biosynthetic process | 0.0404231534720621 |
GO:0007205 | protein kinase C activation | 0.0404231534720621 |
GO:0046165 | alcohol biosynthetic process | 0.0404231534720621 |
GO:0046364 | monosaccharide biosynthetic process | 0.0404231534720621 |
GO:0016251 | general RNA polymerase II transcription factor activity | 0.0431430043764394 |
GO:0008092 | cytoskeletal protein binding | 0.0458074366161085 |
GO:0048869 | cellular developmental process | 0.0476034415930083 |
GO:0030154 | cell differentiation | 0.0476034415930083 |
GO:0016570 | histone modification | 0.048255320498129 |
GO:0009605 | response to external stimulus | 0.048255320498129 |
GO:0051052 | regulation of DNA metabolic process | 0.0484767948771282 |
GO:0030031 | cell projection biogenesis | 0.0485084267640463 |
GO:0016569 | covalent chromatin modification | 0.0485084267640463 |
GO:0030518 | steroid hormone receptor signaling pathway | 0.0485386140891264 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 0.0485386140891264 |
GO:0048608 | reproductive structure development | 0.0485674371638828 |
GO:0008406 | gonad development | 0.0485674371638828 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.